2017. Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics. 72, 5 (May 2017), 317–324. DOI:https://doi.org/10.6061/clinics/2017(05)10.